Nanobac Pharmaceuticals, Incorporated (NNBP)

Nanobac Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Cash & Equivalents	0	0.04	0.01	0.02	0.05
Cash & Short-Term Investments	0	0.04	0.01	0.02	0.05
Cash Growth	-90.04%	340.17%	-49.88%	-64.01%	-
Receivables	0	0	0	0	0.01
Inventory	0.01	0.07	0.12	0.07	0.02
Prepaid Expenses	0.01	0.02	0.04	0.02	-
Other Current Assets	-	-	-	-	0.01
Total Current Assets	0.03	0.13	0.17	0.12	0.09
Property, Plant & Equipment	0.04	0.06	0.11	0.12	0.14
Goodwill	3.62	3.62	3.62	3.62	5.82
Other Intangible Assets	3.53	3.96	5.05	5.76	2.14
Other Long-Term Assets	0.01	0.06	0.02	0.07	0.07
Total Assets	7.22	7.82	8.97	9.68	8.24
Accounts Payable	0.98	0.41	0.31	0.65	0.75
Accrued Expenses	0.77	0.52	0.84	0.39	0.37
Short-Term Debt	4.12	5.37	2.49	0.26	5.73
Other Current Liabilities	0.88	-	0.03	0.02	-
Total Current Liabilities	6.75	6.3	3.67	1.3	6.85
Long-Term Deferred Tax Liabilities	-	-	-	-	2.2
Other Long-Term Liabilities	2.84	2.84	2.84	2.27	-
Total Liabilities	9.58	9.14	6.51	3.57	9.05
Common Stock	22.87	17.26	16.31	16.3	4.23
Additional Paid-In Capital	3.8	3.8	3.5	3.54	-
Retained Earnings	-28.93	-22.35	-17.38	-13.69	-5.17
Comprehensive Income & Other	-0.11	-0.02	0.03	-0.03	-0.22
Total Common Equity	-2.36	-1.31	2.46	6.11	-1.16
Shareholders' Equity	-2.36	-1.31	2.46	6.11	-0.81
Total Liabilities & Equity	7.22	7.82	8.97	9.68	8.24
Total Debt	4.12	5.37	2.49	0.26	5.73
Net Cash (Debt)	-4.12	-5.33	-2.48	-0.24	-5.68
Net Cash Per Share	-0.02	-0.03	-0.01	-0.00	-0.08
Filing Date Shares Outstanding	249.51	247.48	193.51	189.01	139.52
Total Common Shares Outstanding	249.51	205.47	189.01	187.24	99.97
Working Capital	-6.71	-6.17	-3.5	-1.19	-6.76
Book Value Per Share	-0.01	-0.01	0.01	0.03	-0.01
Tangible Book Value	-9.5	-8.89	-6.2	-3.26	-9.11
Tangible Book Value Per Share	-0.04	-0.04	-0.03	-0.02	-0.09
Buildings	-	-	0.05	0.05	0.05
Machinery	0.15	0.17	0.18	0.15	0.13
Leasehold Improvements	-	-	0.05	0.05	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.